Tandem Diabetes Care Inc - Asset Resilience Ratio

Latest as of March 2026: 33.89%

Tandem Diabetes Care Inc (TNDM) has an Asset Resilience Ratio of 33.89% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$390.93 Million

Cash + Short-term Investments

Total Assets

$1.15 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Tandem Diabetes Care Inc's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Tandem Diabetes Care Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Tandem Diabetes Care Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Tandem Diabetes Care Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$390.93 Million	33.89%
Total Liquid Assets	$390.93 Million	33.89%

Asset Resilience Insights

Very High Liquidity: Tandem Diabetes Care Inc maintains exceptional liquid asset reserves at 33.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Tandem Diabetes Care Inc Industry Peers by Asset Resilience Ratio

Compare Tandem Diabetes Care Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Tandem Diabetes Care Inc (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Tandem Diabetes Care Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.93%	$202.03 Million	$881.11 Million	-15.21pp
2024-12-31	38.14%	$369.10 Million	$967.66 Million	-4.79pp
2023-12-31	42.94%	$409.04 Million	$952.66 Million	+0.73pp
2022-12-31	42.21%	$444.38 Million	$1.05 Billion	-18.84pp
2021-12-31	61.05%	$552.63 Million	$905.14 Million	+6.57pp
2020-12-31	54.48%	$390.32 Million	$716.41 Million	+16.07pp
2019-12-31	38.42%	$125.28 Million	$326.11 Million	-3.85pp
2018-12-31	42.27%	$87.20 Million	$206.29 Million	+41.77pp
2017-12-31	0.50%	$479.00K	$95.35 Million	-7.38pp
2016-12-31	7.88%	$8.86 Million	$112.39 Million	-14.51pp
2015-12-31	22.39%	$28.02 Million	$125.12 Million	-11.52pp
2014-12-31	33.91%	$36.11 Million	$106.46 Million	+30.77pp
2013-12-31	3.14%	$5.10 Million	$162.22 Million	+3.02pp
2012-12-31	0.13%	$50.00K	$39.82 Million	-0.23pp
2011-12-31	0.36%	$50.00K	$13.98 Million	--

pp = percentage points

About Tandem Diabetes Care Inc

NASDAQ:TNDM USA Medical Devices

Market Cap

$1.34 Billion

Market Cap Rank

#8601 Global

#2472 in USA

Share Price

$19.50

Change (1 day)

+2.58%

52-Week Range

$10.12 - $28.26

All Time High

$153.21